ºÝºÝߣshows by User: rocheam / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: rocheam / Fri, 14 Jul 2017 20:53:08 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: rocheam How predictive models help Medicinal Chemists design better drugs_webinar /slideshow/how-predictive-models-help-medicinal-chemists-design-better-drugswebinar/77888858 rmc2017predictivemodelswebinar-170714205308
All scientific disciplines, including medicinal chemistry, are experiencing a revolution in unprecedented rates of data being generated and the subsequent analysis and exploitation of this data is increasingly fundamental to innovation. Using data to design better compounds is a challenge for Medicinal and Computational chemists. The design of small-molecule drug candidates, encompassing characteristics such as potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) is a key factor in the success of clinical trials and computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based. In this webinar our expert Dr. Olivier Barberan will discuss ligand-based methods and he will cover the following: How to use only ligand information to predict activity depending on its similarity/dissimilarity to previously known active ligands. - Discuss ligand-based pharmacophores, molecular descriptors, and quantitative structure-activity relationships and important tools such as target/ligand databases necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign. ]]>

All scientific disciplines, including medicinal chemistry, are experiencing a revolution in unprecedented rates of data being generated and the subsequent analysis and exploitation of this data is increasingly fundamental to innovation. Using data to design better compounds is a challenge for Medicinal and Computational chemists. The design of small-molecule drug candidates, encompassing characteristics such as potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) is a key factor in the success of clinical trials and computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based. In this webinar our expert Dr. Olivier Barberan will discuss ligand-based methods and he will cover the following: How to use only ligand information to predict activity depending on its similarity/dissimilarity to previously known active ligands. - Discuss ligand-based pharmacophores, molecular descriptors, and quantitative structure-activity relationships and important tools such as target/ligand databases necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign. ]]>
Fri, 14 Jul 2017 20:53:08 GMT /slideshow/how-predictive-models-help-medicinal-chemists-design-better-drugswebinar/77888858 rocheam@slideshare.net(rocheam) How predictive models help Medicinal Chemists design better drugs_webinar rocheam All scientific disciplines, including medicinal chemistry, are experiencing a revolution in unprecedented rates of data being generated and the subsequent analysis and exploitation of this data is increasingly fundamental to innovation. Using data to design better compounds is a challenge for Medicinal and Computational chemists. The design of small-molecule drug candidates, encompassing characteristics such as potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) is a key factor in the success of clinical trials and computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based. In this webinar our expert Dr. Olivier Barberan will discuss ligand-based methods and he will cover the following: How to use only ligand information to predict activity depending on its similarity/dissimilarity to previously known active ligands. - Discuss ligand-based pharmacophores, molecular descriptors, and quantitative structure-activity relationships and important tools such as target/ligand databases necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/rmc2017predictivemodelswebinar-170714205308-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> All scientific disciplines, including medicinal chemistry, are experiencing a revolution in unprecedented rates of data being generated and the subsequent analysis and exploitation of this data is increasingly fundamental to innovation. Using data to design better compounds is a challenge for Medicinal and Computational chemists. The design of small-molecule drug candidates, encompassing characteristics such as potency, selectivity and ADMET (absorption, distribution, metabolism, excretion and toxicity) is a key factor in the success of clinical trials and computer-aided drug discovery/design methods have played a major role in the development of therapeutically important small molecules for over three decades. These methods are broadly classified as either structure-based or ligand-based. In this webinar our expert Dr. Olivier Barberan will discuss ligand-based methods and he will cover the following: How to use only ligand information to predict activity depending on its similarity/dissimilarity to previously known active ligands. - Discuss ligand-based pharmacophores, molecular descriptors, and quantitative structure-activity relationships and important tools such as target/ligand databases necessary for successful implementation of various computer-aided drug discovery/design methods in a drug discovery campaign.
How predictive models help Medicinal Chemists design better drugs_webinar from Ann-Marie Roche
]]>
787 4 https://cdn.slidesharecdn.com/ss_thumbnails/rmc2017predictivemodelswebinar-170714205308-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Webinar: New RMC - Your lead_optimization Solution June082017 /slideshow/webinar-new-rmc-your-leadoptimization-solution-june082017/76830580 webinarnewrmcwebinarleadoptimizationjune082017-170610215834
The drug discovery landscape is rapidly changing and drives the need to generate leads with lower attrition rates. In this webinar, our expert Dr. Olivier Barberan discussed how NEW Reaxys Medicinal chemistry in NEW Reaxys allows better discovery and exploration of structure activity relationship and also supports a more efficient property-based drug design approach. He covered the following: • How has RMC being transformed into a more accessible tool for all users, allowing complex searches and workflows to be easily carried out. • A demonstration of how more than ever RMC is the only lead-optimization solution you will need. ]]>

The drug discovery landscape is rapidly changing and drives the need to generate leads with lower attrition rates. In this webinar, our expert Dr. Olivier Barberan discussed how NEW Reaxys Medicinal chemistry in NEW Reaxys allows better discovery and exploration of structure activity relationship and also supports a more efficient property-based drug design approach. He covered the following: • How has RMC being transformed into a more accessible tool for all users, allowing complex searches and workflows to be easily carried out. • A demonstration of how more than ever RMC is the only lead-optimization solution you will need. ]]>
Sat, 10 Jun 2017 21:58:34 GMT /slideshow/webinar-new-rmc-your-leadoptimization-solution-june082017/76830580 rocheam@slideshare.net(rocheam) Webinar: New RMC - Your lead_optimization Solution June082017 rocheam The drug discovery landscape is rapidly changing and drives the need to generate leads with lower attrition rates. In this webinar, our expert Dr. Olivier Barberan discussed how NEW Reaxys Medicinal chemistry in NEW Reaxys allows better discovery and exploration of structure activity relationship and also supports a more efficient property-based drug design approach. He covered the following: • How has RMC being transformed into a more accessible tool for all users, allowing complex searches and workflows to be easily carried out. • A demonstration of how more than ever RMC is the only lead-optimization solution you will need. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/webinarnewrmcwebinarleadoptimizationjune082017-170610215834-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The drug discovery landscape is rapidly changing and drives the need to generate leads with lower attrition rates. In this webinar, our expert Dr. Olivier Barberan discussed how NEW Reaxys Medicinal chemistry in NEW Reaxys allows better discovery and exploration of structure activity relationship and also supports a more efficient property-based drug design approach. He covered the following: • How has RMC being transformed into a more accessible tool for all users, allowing complex searches and workflows to be easily carried out. • A demonstration of how more than ever RMC is the only lead-optimization solution you will need.
Webinar: New RMC - Your lead_optimization Solution June082017 from Ann-Marie Roche
]]>
615 9 https://cdn.slidesharecdn.com/ss_thumbnails/webinarnewrmcwebinarleadoptimizationjune082017-170610215834-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari /slideshow/oilgas-thought-leader-webinar-new-plays-for-old-ideas-drgabor-tari/75592447 tlwebinaraprilgabor-170502083828
In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Gabor Tari is currently the Group Chief Geologist at OMV. He has over 20 years’ experience working in upstream oil & gas and has worked for Amoco, BP, and Vanco, before joining OMV in 2007. Gabor has worked on exploration projects in basins around the globe, including Romania, Angola, North Africa, and the Middle East. He has authored over 50 scientific publications, presented papers at dozens of conferences, and most recently co-authored the book Permo-Triassic Salt Provinces of Europe, North Africa and the Atlantic Margins, with Dr Joan Flinch (Repsol) and Juan Soto, Professor of Geodynamics in the Granada University and in the Instituto Andaluz de Ciencias de la Tierra, Spain, which is currently available from Elsevier for pre-order online. Gabor discussed and shared some examples of how new plays can be built on a solid foundation of petroleum system development and research, and how new ideas can be garnered from building on published research of oil & gas companies, academia, service providers and consultants. ]]>

In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Gabor Tari is currently the Group Chief Geologist at OMV. He has over 20 years’ experience working in upstream oil & gas and has worked for Amoco, BP, and Vanco, before joining OMV in 2007. Gabor has worked on exploration projects in basins around the globe, including Romania, Angola, North Africa, and the Middle East. He has authored over 50 scientific publications, presented papers at dozens of conferences, and most recently co-authored the book Permo-Triassic Salt Provinces of Europe, North Africa and the Atlantic Margins, with Dr Joan Flinch (Repsol) and Juan Soto, Professor of Geodynamics in the Granada University and in the Instituto Andaluz de Ciencias de la Tierra, Spain, which is currently available from Elsevier for pre-order online. Gabor discussed and shared some examples of how new plays can be built on a solid foundation of petroleum system development and research, and how new ideas can be garnered from building on published research of oil & gas companies, academia, service providers and consultants. ]]>
Tue, 02 May 2017 08:38:28 GMT /slideshow/oilgas-thought-leader-webinar-new-plays-for-old-ideas-drgabor-tari/75592447 rocheam@slideshare.net(rocheam) Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari rocheam In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Gabor Tari is currently the Group Chief Geologist at OMV. He has over 20 years’ experience working in upstream oil & gas and has worked for Amoco, BP, and Vanco, before joining OMV in 2007. Gabor has worked on exploration projects in basins around the globe, including Romania, Angola, North Africa, and the Middle East. He has authored over 50 scientific publications, presented papers at dozens of conferences, and most recently co-authored the book Permo-Triassic Salt Provinces of Europe, North Africa and the Atlantic Margins, with Dr Joan Flinch (Repsol) and Juan Soto, Professor of Geodynamics in the Granada University and in the Instituto Andaluz de Ciencias de la Tierra, Spain, which is currently available from Elsevier for pre-order online. Gabor discussed and shared some examples of how new plays can be built on a solid foundation of petroleum system development and research, and how new ideas can be garnered from building on published research of oil & gas companies, academia, service providers and consultants. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilgabor-170502083828-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Gabor Tari is currently the Group Chief Geologist at OMV. He has over 20 years’ experience working in upstream oil &amp; gas and has worked for Amoco, BP, and Vanco, before joining OMV in 2007. Gabor has worked on exploration projects in basins around the globe, including Romania, Angola, North Africa, and the Middle East. He has authored over 50 scientific publications, presented papers at dozens of conferences, and most recently co-authored the book Permo-Triassic Salt Provinces of Europe, North Africa and the Atlantic Margins, with Dr Joan Flinch (Repsol) and Juan Soto, Professor of Geodynamics in the Granada University and in the Instituto Andaluz de Ciencias de la Tierra, Spain, which is currently available from Elsevier for pre-order online. Gabor discussed and shared some examples of how new plays can be built on a solid foundation of petroleum system development and research, and how new ideas can be garnered from building on published research of oil &amp; gas companies, academia, service providers and consultants.
Oil&Gas Thought Leader Webinar - New Plays for Old Ideas - Dr.Gabor Tari from Ann-Marie Roche
]]>
772 6 https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilgabor-170502083828-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner /slideshow/oilgas-thoughtleader-webinar-new-plays-for-old-ideas-dr-rob-forkner/75563178 tlwebinaraprilrobforkner-170501113534
In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Rob Forkner is a carbonate geologist at Statoil, working in the carbonate plays and reservoirs research group in Austin, Texas, focusing on carbonate play prediction in Atlantic margin systems. Prior to Statoil, Rob worked at Maersk and Shell in onshore and offshore in well planning, geosteering, high-resolution sequence stratigraphy and facies prediction, carbonate sedimentology in unconventional assets, evaporite classification and prediction, rock typing, and more recently, carbonate system suppression and recovery during Oceanic Anoxic Events. ]]>

In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Rob Forkner is a carbonate geologist at Statoil, working in the carbonate plays and reservoirs research group in Austin, Texas, focusing on carbonate play prediction in Atlantic margin systems. Prior to Statoil, Rob worked at Maersk and Shell in onshore and offshore in well planning, geosteering, high-resolution sequence stratigraphy and facies prediction, carbonate sedimentology in unconventional assets, evaporite classification and prediction, rock typing, and more recently, carbonate system suppression and recovery during Oceanic Anoxic Events. ]]>
Mon, 01 May 2017 11:35:34 GMT /slideshow/oilgas-thoughtleader-webinar-new-plays-for-old-ideas-dr-rob-forkner/75563178 rocheam@slideshare.net(rocheam) Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner rocheam In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Rob Forkner is a carbonate geologist at Statoil, working in the carbonate plays and reservoirs research group in Austin, Texas, focusing on carbonate play prediction in Atlantic margin systems. Prior to Statoil, Rob worked at Maersk and Shell in onshore and offshore in well planning, geosteering, high-resolution sequence stratigraphy and facies prediction, carbonate sedimentology in unconventional assets, evaporite classification and prediction, rock typing, and more recently, carbonate system suppression and recovery during Oceanic Anoxic Events. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilrobforkner-170501113534-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr Rob Forkner is a carbonate geologist at Statoil, working in the carbonate plays and reservoirs research group in Austin, Texas, focusing on carbonate play prediction in Atlantic margin systems. Prior to Statoil, Rob worked at Maersk and Shell in onshore and offshore in well planning, geosteering, high-resolution sequence stratigraphy and facies prediction, carbonate sedimentology in unconventional assets, evaporite classification and prediction, rock typing, and more recently, carbonate system suppression and recovery during Oceanic Anoxic Events.
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Rob Forkner from Ann-Marie Roche
]]>
505 4 https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilrobforkner-170501113534-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben /slideshow/oilgas-thoughtleader-webinar-new-plays-for-old-ideas-dr-sander-houben/75563177 tlwebinaraprilalexanderhouben-170501113533
In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr. Sander Houben is a biostratrapher and researcher within the Basin Analysis team at TNO, Netherlands Organisation for Applied Scientific Research, and the leading research institute for applied sciences in the Netherlands. As part of the Basin Analysis Team, Sander provides scientific and technical expertise regarding stratigraphic and paleo-environmental constraints for multidisciplinary projects. In addition to conducting research, he leads TNO’s biostratigraphic consultancy research programs. ]]>

In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr. Sander Houben is a biostratrapher and researcher within the Basin Analysis team at TNO, Netherlands Organisation for Applied Scientific Research, and the leading research institute for applied sciences in the Netherlands. As part of the Basin Analysis Team, Sander provides scientific and technical expertise regarding stratigraphic and paleo-environmental constraints for multidisciplinary projects. In addition to conducting research, he leads TNO’s biostratigraphic consultancy research programs. ]]>
Mon, 01 May 2017 11:35:33 GMT /slideshow/oilgas-thoughtleader-webinar-new-plays-for-old-ideas-dr-sander-houben/75563177 rocheam@slideshare.net(rocheam) Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben rocheam In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr. Sander Houben is a biostratrapher and researcher within the Basin Analysis team at TNO, Netherlands Organisation for Applied Scientific Research, and the leading research institute for applied sciences in the Netherlands. As part of the Basin Analysis Team, Sander provides scientific and technical expertise regarding stratigraphic and paleo-environmental constraints for multidisciplinary projects. In addition to conducting research, he leads TNO’s biostratigraphic consultancy research programs. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilalexanderhouben-170501113533-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In our April 2017 webinar, three industry experts shared their research and demonstrated the importance of focusing on fundamental geologic and geophysical research approaches that integrate variety of data, information and concepts from disparate sources and related disciplines. This back-to-fundamentals research can both inspire and accelerate exploration teams’ thinking about petroleum systems and lead to a path to success. Dr. Sander Houben is a biostratrapher and researcher within the Basin Analysis team at TNO, Netherlands Organisation for Applied Scientific Research, and the leading research institute for applied sciences in the Netherlands. As part of the Basin Analysis Team, Sander provides scientific and technical expertise regarding stratigraphic and paleo-environmental constraints for multidisciplinary projects. In addition to conducting research, he leads TNO’s biostratigraphic consultancy research programs.
Oil&Gas Thought-Leader Webinar - New Plays for Old Ideas - Dr. Sander Houben from Ann-Marie Roche
]]>
549 8 https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilalexanderhouben-170501113533-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Embase for pharmacovigilance: Search and validation March 22 2017 /slideshow/embase-for-pharmacovigilance-search-and-validation-march-22-2017/73588148 embaseforpharmacovigilance-pvsearchandvalidationv1-170324124946
Scientific literature plays a critical role in Pharmacovigilance and Drug Safety workflows. Monitoring literature for mentions of adverse drug reactions (ADRs) is mandated by regulatory bodies, and marketing authorization holders (MAHs) that do not properly report ADRs can be subject to heavy fines. With an increasing volume of unstructured content to cover, along with rising labor costs, MAHs are looking for ways to make their literature monitoring more effective and efficient. Abstract and indexing (A&I) databases play an important role in Literature Monitoring – due to the vast amount of scientific literature published daily – in order for MAH’s to locate specific articles or conference presentations that may be relevant for their products (for both benefit/risk analysis and ADR detection). Rather than reading all the literature, MAH’s create search strategies that identify the relevant records in A&I databases and execute the searches regularly. GVP module VI mandates that searches are done at least weekly, but many companies maintain a daily monitoring and review cycle. In this webinar, Senior Product Development Manager Embase, Dr. Ivan Krstic discussed best practices for saving time, staying current, validating search strategies and mitigating risk in the face of these increasingly complex processes in literature monitoring]]>

Scientific literature plays a critical role in Pharmacovigilance and Drug Safety workflows. Monitoring literature for mentions of adverse drug reactions (ADRs) is mandated by regulatory bodies, and marketing authorization holders (MAHs) that do not properly report ADRs can be subject to heavy fines. With an increasing volume of unstructured content to cover, along with rising labor costs, MAHs are looking for ways to make their literature monitoring more effective and efficient. Abstract and indexing (A&I) databases play an important role in Literature Monitoring – due to the vast amount of scientific literature published daily – in order for MAH’s to locate specific articles or conference presentations that may be relevant for their products (for both benefit/risk analysis and ADR detection). Rather than reading all the literature, MAH’s create search strategies that identify the relevant records in A&I databases and execute the searches regularly. GVP module VI mandates that searches are done at least weekly, but many companies maintain a daily monitoring and review cycle. In this webinar, Senior Product Development Manager Embase, Dr. Ivan Krstic discussed best practices for saving time, staying current, validating search strategies and mitigating risk in the face of these increasingly complex processes in literature monitoring]]>
Fri, 24 Mar 2017 12:49:45 GMT /slideshow/embase-for-pharmacovigilance-search-and-validation-march-22-2017/73588148 rocheam@slideshare.net(rocheam) Embase for pharmacovigilance: Search and validation March 22 2017 rocheam Scientific literature plays a critical role in Pharmacovigilance and Drug Safety workflows. Monitoring literature for mentions of adverse drug reactions (ADRs) is mandated by regulatory bodies, and marketing authorization holders (MAHs) that do not properly report ADRs can be subject to heavy fines. With an increasing volume of unstructured content to cover, along with rising labor costs, MAHs are looking for ways to make their literature monitoring more effective and efficient. Abstract and indexing (A&I) databases play an important role in Literature Monitoring – due to the vast amount of scientific literature published daily – in order for MAH’s to locate specific articles or conference presentations that may be relevant for their products (for both benefit/risk analysis and ADR detection). Rather than reading all the literature, MAH’s create search strategies that identify the relevant records in A&I databases and execute the searches regularly. GVP module VI mandates that searches are done at least weekly, but many companies maintain a daily monitoring and review cycle. In this webinar, Senior Product Development Manager Embase, Dr. Ivan Krstic discussed best practices for saving time, staying current, validating search strategies and mitigating risk in the face of these increasingly complex processes in literature monitoring <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/embaseforpharmacovigilance-pvsearchandvalidationv1-170324124946-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Scientific literature plays a critical role in Pharmacovigilance and Drug Safety workflows. Monitoring literature for mentions of adverse drug reactions (ADRs) is mandated by regulatory bodies, and marketing authorization holders (MAHs) that do not properly report ADRs can be subject to heavy fines. With an increasing volume of unstructured content to cover, along with rising labor costs, MAHs are looking for ways to make their literature monitoring more effective and efficient. Abstract and indexing (A&amp;I) databases play an important role in Literature Monitoring – due to the vast amount of scientific literature published daily – in order for MAH’s to locate specific articles or conference presentations that may be relevant for their products (for both benefit/risk analysis and ADR detection). Rather than reading all the literature, MAH’s create search strategies that identify the relevant records in A&amp;I databases and execute the searches regularly. GVP module VI mandates that searches are done at least weekly, but many companies maintain a daily monitoring and review cycle. In this webinar, Senior Product Development Manager Embase, Dr. Ivan Krstic discussed best practices for saving time, staying current, validating search strategies and mitigating risk in the face of these increasingly complex processes in literature monitoring
Embase for pharmacovigilance: Search and validation March 22 2017 from Ann-Marie Roche
]]>
2134 5 https://cdn.slidesharecdn.com/ss_thumbnails/embaseforpharmacovigilance-pvsearchandvalidationv1-170324124946-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Literature Management for Pharmacovigilance: Outsource or in-house solution? 21 March 2017 /slideshow/literature-management-for-pharmacovigilance-outsource-or-inhouse-solution-21-march-2017/73507663 webinar21mar2017-170322221228
Pharmaceutical companies are required to screen scientific literature on a regular basis and this comes with many challenges, such as handling large amounts of data, building search strings and integrating EMA MLM results. Out-sourcing literature screening to service providers reduces the workload for the PV-team, but how does it impact the literature management process overall? Maybe it results in decreased oversight and additional activities like audits and reconciliation? And what about building the search strategy? During this webinar our PV expert, Dr. Joyce De Langen spoke about the following: • The importance of literature management in Pharmacovigilance and the challenges. • An evaluation of the benefits and risks of outsourcing literature management versus alternative solutions. About the speaker: Joyce de Langen, Ph.D has more than 10 years of experience in the domain of pharmacovigilance and drug safety. Through her work in the pharmaceutical industry, academia and regulatory authorities, Joyce has developed a broad perspective and knowledge in pharmacovigilance and drug safety. ]]>

Pharmaceutical companies are required to screen scientific literature on a regular basis and this comes with many challenges, such as handling large amounts of data, building search strings and integrating EMA MLM results. Out-sourcing literature screening to service providers reduces the workload for the PV-team, but how does it impact the literature management process overall? Maybe it results in decreased oversight and additional activities like audits and reconciliation? And what about building the search strategy? During this webinar our PV expert, Dr. Joyce De Langen spoke about the following: • The importance of literature management in Pharmacovigilance and the challenges. • An evaluation of the benefits and risks of outsourcing literature management versus alternative solutions. About the speaker: Joyce de Langen, Ph.D has more than 10 years of experience in the domain of pharmacovigilance and drug safety. Through her work in the pharmaceutical industry, academia and regulatory authorities, Joyce has developed a broad perspective and knowledge in pharmacovigilance and drug safety. ]]>
Wed, 22 Mar 2017 22:12:28 GMT /slideshow/literature-management-for-pharmacovigilance-outsource-or-inhouse-solution-21-march-2017/73507663 rocheam@slideshare.net(rocheam) Literature Management for Pharmacovigilance: Outsource or in-house solution? 21 March 2017 rocheam Pharmaceutical companies are required to screen scientific literature on a regular basis and this comes with many challenges, such as handling large amounts of data, building search strings and integrating EMA MLM results. Out-sourcing literature screening to service providers reduces the workload for the PV-team, but how does it impact the literature management process overall? Maybe it results in decreased oversight and additional activities like audits and reconciliation? And what about building the search strategy? During this webinar our PV expert, Dr. Joyce De Langen spoke about the following: • The importance of literature management in Pharmacovigilance and the challenges. • An evaluation of the benefits and risks of outsourcing literature management versus alternative solutions. About the speaker: Joyce de Langen, Ph.D has more than 10 years of experience in the domain of pharmacovigilance and drug safety. Through her work in the pharmaceutical industry, academia and regulatory authorities, Joyce has developed a broad perspective and knowledge in pharmacovigilance and drug safety. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/webinar21mar2017-170322221228-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Pharmaceutical companies are required to screen scientific literature on a regular basis and this comes with many challenges, such as handling large amounts of data, building search strings and integrating EMA MLM results. Out-sourcing literature screening to service providers reduces the workload for the PV-team, but how does it impact the literature management process overall? Maybe it results in decreased oversight and additional activities like audits and reconciliation? And what about building the search strategy? During this webinar our PV expert, Dr. Joyce De Langen spoke about the following: • The importance of literature management in Pharmacovigilance and the challenges. • An evaluation of the benefits and risks of outsourcing literature management versus alternative solutions. About the speaker: Joyce de Langen, Ph.D has more than 10 years of experience in the domain of pharmacovigilance and drug safety. Through her work in the pharmaceutical industry, academia and regulatory authorities, Joyce has developed a broad perspective and knowledge in pharmacovigilance and drug safety.
Literature Management for Pharmacovigilance: Outsource or in-house solution? 21 March 2017 from Ann-Marie Roche
]]>
2002 9 https://cdn.slidesharecdn.com/ss_thumbnails/webinar21mar2017-170322221228-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Finding the right medical device information in embase 11 2016 /slideshow/finding-the-right-medical-device-information-in-embase-11-2016/69107298 findingtherightmedicaldeviceinformationinembase112016-161116165540
Finding the right medical device information in embase]]>

Finding the right medical device information in embase]]>
Wed, 16 Nov 2016 16:55:40 GMT /slideshow/finding-the-right-medical-device-information-in-embase-11-2016/69107298 rocheam@slideshare.net(rocheam) Finding the right medical device information in embase 11 2016 rocheam Finding the right medical device information in embase <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/findingtherightmedicaldeviceinformationinembase112016-161116165540-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Finding the right medical device information in embase
Finding the right medical device information in embase 11 2016 from Ann-Marie Roche
]]>
960 6 https://cdn.slidesharecdn.com/ss_thumbnails/findingtherightmedicaldeviceinformationinembase112016-161116165540-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Medical device reporting 27 sep2016 /slideshow/medical-device-reporting-27-sep2016/66523533 medicaldevicereporting27sep2016-160928175959
Medical Device Reporting ]]>

Medical Device Reporting ]]>
Wed, 28 Sep 2016 17:59:58 GMT /slideshow/medical-device-reporting-27-sep2016/66523533 rocheam@slideshare.net(rocheam) Medical device reporting 27 sep2016 rocheam Medical Device Reporting <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/medicaldevicereporting27sep2016-160928175959-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Medical Device Reporting
Medical device reporting 27 sep2016 from Ann-Marie Roche
]]>
7049 9 https://cdn.slidesharecdn.com/ss_thumbnails/medicaldevicereporting27sep2016-160928175959-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Eac webinar 09.21.2016 /slideshow/eac-webinar-09212016-66268672/66268672 eacwebinar09-160921172144
The All-New 2016 Engineering Academic Challenge - developed by students for students The Engineering Academic Challenge (formerly as the Knovel Academic Challenge) is an immersive, 5-week interactive problem-set competition, featuring weekly thematic engineering challenges built around five transdisciplinary themes inspired by the National Academy of Engineering Grand Challenges. ]]>

The All-New 2016 Engineering Academic Challenge - developed by students for students The Engineering Academic Challenge (formerly as the Knovel Academic Challenge) is an immersive, 5-week interactive problem-set competition, featuring weekly thematic engineering challenges built around five transdisciplinary themes inspired by the National Academy of Engineering Grand Challenges. ]]>
Wed, 21 Sep 2016 17:21:44 GMT /slideshow/eac-webinar-09212016-66268672/66268672 rocheam@slideshare.net(rocheam) Eac webinar 09.21.2016 rocheam The All-New 2016 Engineering Academic Challenge - developed by students for students The Engineering Academic Challenge (formerly as the Knovel Academic Challenge) is an immersive, 5-week interactive problem-set competition, featuring weekly thematic engineering challenges built around five transdisciplinary themes inspired by the National Academy of Engineering Grand Challenges. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/eacwebinar09-160921172144-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The All-New 2016 Engineering Academic Challenge - developed by students for students The Engineering Academic Challenge (formerly as the Knovel Academic Challenge) is an immersive, 5-week interactive problem-set competition, featuring weekly thematic engineering challenges built around five transdisciplinary themes inspired by the National Academy of Engineering Grand Challenges.
Eac webinar 09.21.2016 from Ann-Marie Roche
]]>
305 4 https://cdn.slidesharecdn.com/ss_thumbnails/eacwebinar09-160921172144-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Literature monitoring for pv what are we doing at galderma elsevier webinar /slideshow/literature-monitoring-for-pv-what-are-we-doing-at-galderma-elsevier-webinar/64743094 literaturemonitoringforpv-whatarewedoingatgaldermaelsevierwebinar-160805192105
Literature monitoring for Pharmacovigilance]]>

Literature monitoring for Pharmacovigilance]]>
Fri, 05 Aug 2016 19:21:05 GMT /slideshow/literature-monitoring-for-pv-what-are-we-doing-at-galderma-elsevier-webinar/64743094 rocheam@slideshare.net(rocheam) Literature monitoring for pv what are we doing at galderma elsevier webinar rocheam Literature monitoring for Pharmacovigilance <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/literaturemonitoringforpv-whatarewedoingatgaldermaelsevierwebinar-160805192105-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Literature monitoring for Pharmacovigilance
Literature monitoring for pv what are we doing at galderma elsevier webinar from Ann-Marie Roche
]]>
3416 10 https://cdn.slidesharecdn.com/ss_thumbnails/literaturemonitoringforpv-whatarewedoingatgaldermaelsevierwebinar-160805192105-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Drug analytics based on triple linking v1.0 /slideshow/drug-analytics-based-on-triple-linking-v10/64447277 druganalyticsbasedontriple-linkingv1-160727180826
Drug Analytics in Embase]]>

Drug Analytics in Embase]]>
Wed, 27 Jul 2016 18:08:26 GMT /slideshow/drug-analytics-based-on-triple-linking-v10/64447277 rocheam@slideshare.net(rocheam) Drug analytics based on triple linking v1.0 rocheam Drug Analytics in Embase <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/druganalyticsbasedontriple-linkingv1-160727180826-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Drug Analytics in Embase
Drug analytics based on triple linking v1.0 from Ann-Marie Roche
]]>
6156 7 https://cdn.slidesharecdn.com/ss_thumbnails/druganalyticsbasedontriple-linkingv1-160727180826-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Knovel lss webinar /slideshow/knovel-lss-webinar/64210518 knovellsswebinar-160720151341
Lean Six Sigma Excellence with Knovel]]>

Lean Six Sigma Excellence with Knovel]]>
Wed, 20 Jul 2016 15:13:41 GMT /slideshow/knovel-lss-webinar/64210518 rocheam@slideshare.net(rocheam) Knovel lss webinar rocheam Lean Six Sigma Excellence with Knovel <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/knovellsswebinar-160720151341-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Lean Six Sigma Excellence with Knovel
Knovel lss webinar from Ann-Marie Roche
]]>
1159 6 https://cdn.slidesharecdn.com/ss_thumbnails/knovellsswebinar-160720151341-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Reaxys rmc unified platform_ webinar_ /slideshow/reaxys-rmc-unified-platform-webinar/63396156 reaxysrmcunifiedplatformwebinar-160623234644
Learn how Reaxys handles data from multiple sources]]>

Learn how Reaxys handles data from multiple sources]]>
Thu, 23 Jun 2016 23:46:44 GMT /slideshow/reaxys-rmc-unified-platform-webinar/63396156 rocheam@slideshare.net(rocheam) Reaxys rmc unified platform_ webinar_ rocheam Learn how Reaxys handles data from multiple sources <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reaxysrmcunifiedplatformwebinar-160623234644-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Learn how Reaxys handles data from multiple sources
Reaxys rmc unified platform_ webinar_ from Ann-Marie Roche
]]>
748 8 https://cdn.slidesharecdn.com/ss_thumbnails/reaxysrmcunifiedplatformwebinar-160623234644-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Pathway studiosymposium lorenzi /slideshow/pathway-studiosymposium-lorenzi/63298566 pathwaystudiosymposiumlorenzi-160621152742
Census of the Apoptosis Pathway]]>

Census of the Apoptosis Pathway]]>
Tue, 21 Jun 2016 15:27:42 GMT /slideshow/pathway-studiosymposium-lorenzi/63298566 rocheam@slideshare.net(rocheam) Pathway studiosymposium lorenzi rocheam Census of the Apoptosis Pathway <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pathwaystudiosymposiumlorenzi-160621152742-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Census of the Apoptosis Pathway
Pathway studiosymposium lorenzi from Ann-Marie Roche
]]>
892 6 https://cdn.slidesharecdn.com/ss_thumbnails/pathwaystudiosymposiumlorenzi-160621152742-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Searching literature databases for post authorisation safety studies (pass) /slideshow/searching-literature-databases-for-post-authorisation-safety-studies-pass/63139631 searchingliteraturedatabasesforpost-authorisationsafetystudiespass-160616135454
Searching literature databases for post authorisation safety studies (pass)]]>

Searching literature databases for post authorisation safety studies (pass)]]>
Thu, 16 Jun 2016 13:54:54 GMT /slideshow/searching-literature-databases-for-post-authorisation-safety-studies-pass/63139631 rocheam@slideshare.net(rocheam) Searching literature databases for post authorisation safety studies (pass) rocheam Searching literature databases for post authorisation safety studies (pass) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/searchingliteraturedatabasesforpost-authorisationsafetystudiespass-160616135454-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Searching literature databases for post authorisation safety studies (pass)
Searching literature databases for post authorisation safety studies (pass) from Ann-Marie Roche
]]>
6565 9 https://cdn.slidesharecdn.com/ss_thumbnails/searchingliteraturedatabasesforpost-authorisationsafetystudiespass-160616135454-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Julie glanville embase sunrise seminar may 2016 /slideshow/julie-glanville-embase-sunrise-seminar-may-2016/62653305 julieglanvilleembasesunriseseminarmay2016-160602111911
Embase Sunrise Seminar]]>

Embase Sunrise Seminar]]>
Thu, 02 Jun 2016 11:19:11 GMT /slideshow/julie-glanville-embase-sunrise-seminar-may-2016/62653305 rocheam@slideshare.net(rocheam) Julie glanville embase sunrise seminar may 2016 rocheam Embase Sunrise Seminar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/julieglanvilleembasesunriseseminarmay2016-160602111911-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Embase Sunrise Seminar
Julie glanville embase sunrise seminar may 2016 from Ann-Marie Roche
]]>
828 9 https://cdn.slidesharecdn.com/ss_thumbnails/julieglanvilleembasesunriseseminarmay2016-160602111911-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Ian crowlesmith embase retrospective mla 2016 /slideshow/ian-crowlesmith-embase-retrospective-mla-2016/62653252 iancrowlesmith-embaseretrospectivemla2016-160602111734
Embase Sunrise Seminar]]>

Embase Sunrise Seminar]]>
Thu, 02 Jun 2016 11:17:34 GMT /slideshow/ian-crowlesmith-embase-retrospective-mla-2016/62653252 rocheam@slideshare.net(rocheam) Ian crowlesmith embase retrospective mla 2016 rocheam Embase Sunrise Seminar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iancrowlesmith-embaseretrospectivemla2016-160602111734-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Embase Sunrise Seminar
Ian crowlesmith embase retrospective mla 2016 from Ann-Marie Roche
]]>
388 5 https://cdn.slidesharecdn.com/ss_thumbnails/iancrowlesmith-embaseretrospectivemla2016-160602111734-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Ivan krstic embase update mla 2016 /slideshow/ivan-krstic-embase-update-mla-2016/62653246 ivankrstic-embaseupdatemla2016-160602111730
Embase Sunrise Seminar]]>

Embase Sunrise Seminar]]>
Thu, 02 Jun 2016 11:17:30 GMT /slideshow/ivan-krstic-embase-update-mla-2016/62653246 rocheam@slideshare.net(rocheam) Ivan krstic embase update mla 2016 rocheam Embase Sunrise Seminar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ivankrstic-embaseupdatemla2016-160602111730-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Embase Sunrise Seminar
Ivan krstic embase update mla 2016 from Ann-Marie Roche
]]>
642 7 https://cdn.slidesharecdn.com/ss_thumbnails/ivankrstic-embaseupdatemla2016-160602111730-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
Kp bloch psm preparedness final rev /slideshow/kp-bloch-psm-preparedness-final-rev/62437440 kpblochpsmpreparednessfinalrev-160526171947
Learn about process safety management]]>

Learn about process safety management]]>
Thu, 26 May 2016 17:19:47 GMT /slideshow/kp-bloch-psm-preparedness-final-rev/62437440 rocheam@slideshare.net(rocheam) Kp bloch psm preparedness final rev rocheam Learn about process safety management <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/kpblochpsmpreparednessfinalrev-160526171947-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Learn about process safety management
Kp bloch psm preparedness final rev from Ann-Marie Roche
]]>
1384 6 https://cdn.slidesharecdn.com/ss_thumbnails/kpblochpsmpreparednessfinalrev-160526171947-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 1
https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/rmc2017predictivemodelswebinar-170714205308-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/how-predictive-models-help-medicinal-chemists-design-better-drugswebinar/77888858 How predictive models ... https://cdn.slidesharecdn.com/ss_thumbnails/webinarnewrmcwebinarleadoptimizationjune082017-170610215834-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/webinar-new-rmc-your-leadoptimization-solution-june082017/76830580 Webinar: New RMC - You... https://cdn.slidesharecdn.com/ss_thumbnails/tlwebinaraprilgabor-170502083828-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/oilgas-thought-leader-webinar-new-plays-for-old-ideas-drgabor-tari/75592447 Oil&amp;Gas Thought Leader...